Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio as Biomarkers for Cardiovascular Surgery Procedures: A Literature Review

Rev Recent Clin Trials. 2021;16(2):173-179. doi: 10.2174/1574887115999201027145406.

Abstract

Background: Neutrophil-to-lymphocyte ratio (NLR) and the platelet-to-lymphocyte ratio (PLR) have been studied so far as prognostic factors of cardiovascular diseases. Their role interplayed with endothelial inflammation has emerged as optimal predictors for major cardiovascular disease events and prognostic factors for post-procedural outcomes.

Methods: A review of the current literature was undertaken to investigate the relationship between NLR and PLR with percutaneous, cardiac surgery, and vascular surgery procedures.

Results: Our findings show that perioperative NLR and PLR levels are significantly correlated with patient morbidity and mortality rates.

Conclusion: These biomarkers have several attractive characteristics, as they are inexpensive and quickly available, and they can contribute to the early identification of patients at high risk for periprocedural adverse events.

Keywords: NLR; Neutrophil-to-lymphocyte ratio; PLR; cardiac surgery; endovascular; outcome; platelet-to-lymphocyte ratio; precision medicine; surgery; vascular surgery.

Publication types

  • Review

MeSH terms

  • Biomarkers
  • Humans
  • Lymphocyte Count
  • Lymphocytes*
  • Neutrophils*
  • Platelet Count
  • Prognosis

Substances

  • Biomarkers